BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//EAHAD - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.eahad.org
X-WR-CALDESC:Events for EAHAD
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20251202T200000
DTEND;TZID=Europe/Brussels:20251202T210000
DTSTAMP:20260506T182556
CREATED:20251021T141614Z
LAST-MODIFIED:20251021T141614Z
UID:30483-1764705600-1764709200@www.eahad.org
SUMMARY:IHS Clinical Webinar Series 2025: Update on Mimetics
DESCRIPTION:Featuring Dr. Peter Lenting\, National Institute for Health and Medical Research\, Paris.
URL:https://www.eahad.org/event/ihs-clinical-webinar-series-2025-update-on-mimetics/
LOCATION:Online
CATEGORIES:Partnership
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251206
DTEND;VALUE=DATE:20251210
DTSTAMP:20260506T182556
CREATED:20251020T173631Z
LAST-MODIFIED:20251020T174919Z
UID:30407-1764979200-1765324799@www.eahad.org
SUMMARY:ASH Annual Meeting
DESCRIPTION:The American Society of Hematology  (ASH) Annual Meeting is the world’s largest and most comprehensive haematology event of the year. With hundreds of sessions showcasing the latest research and practice trends in haematology\, ASH offers multiple ways for attendees to find exactly what they are looking for.
URL:https://www.eahad.org/event/ash-annual-meeting/
LOCATION:Orlando\, Florida\, United States
CATEGORIES:Nurses
ORGANIZER;CN="The American Society of Hematology":MAILTO:https://www.hematology.org/Meetings/Annual-Meeting
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20251211T200000
DTEND;TZID=Europe/Brussels:20251211T210000
DTSTAMP:20260506T182556
CREATED:20251021T141705Z
LAST-MODIFIED:20251021T141705Z
UID:30486-1765483200-1765486800@www.eahad.org
SUMMARY:IHS Clinical Webinar Series 2025: Access to Treatment – What Has Been Achieved Globally and What is Needed
DESCRIPTION:Featuring Dr. Glenn Pierce\, Vice President Medical of the World Federation of Hemophilia (WFH)\, USA
URL:https://www.eahad.org/event/ihs-clinical-webinar-series-2025-access-to-treatment-what-has-been-achieved-globally-and-what-is-needed/
LOCATION:Online
CATEGORIES:Partnership
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260110
DTEND;VALUE=DATE:20260111
DTSTAMP:20260506T182556
CREATED:20260409T132525Z
LAST-MODIFIED:20260409T133724Z
UID:30973-1768003200-1768089599@www.eahad.org
SUMMARY:E-Learning Module 21: When to consider Ehlers-Danlos Syndromes in a patient with haemorrhagic symptoms
DESCRIPTION:Join Dr Karelle Benistan\, leading expert from the French reference centre for non-vascular EDS\, as she guides you through the diagnosis and management of EDS from a haematology perspective. Gain practical insights into recognising clinical features\, understanding bleeding risks\, and optimising patient care.
URL:https://www.eahad.org/event/e-learning-module-21-when-to-consider-ehlers-danlos-syndromes-in-a-patient-with-haemorrhagic-symptoms/
LOCATION:EAHAD Academy
CATEGORIES:2026,Events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260203
DTEND;VALUE=DATE:20260207
DTSTAMP:20260506T182556
CREATED:20251008T094345Z
LAST-MODIFIED:20251020T173846Z
UID:29755-1770076800-1770422399@www.eahad.org
SUMMARY:EAHAD 2026 Congress
DESCRIPTION:
URL:https://www.eahad.org/event/eahad-2026-congress/
LOCATION:The Convention Centre Dublin\, Spencer Dock\, N Wall Quay\, North Wall\, Dublin 1\, D01 T1W6\, Ireland\, Dublin\, Ireland
CATEGORIES:2026,Events,Nurses
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260406
DTEND;VALUE=DATE:20260407
DTSTAMP:20260506T182556
CREATED:20260409T133628Z
LAST-MODIFIED:20260409T133628Z
UID:30993-1775433600-1775519999@www.eahad.org
SUMMARY:Revisiting the role of FVIII in Haemophilia A in 2026
DESCRIPTION:Cedric Hermans sits down with Jan Blatný\, Consultant Haematologist at Masaryk University and University Hospital Brno\, EHCC and EuroBloodNet Centre\, and former EAHAD President (2024–2026)\, to explore the evolving role of Factor VIII in the management of haemophilia A in 2026. As new therapies such as emicizumab\, rebalancing agents\, and gene therapy reshape the treatment landscape\, this conversation revisits where FVIII remains essential.
URL:https://www.eahad.org/event/revisiting-the-role-of-fviii-in-haemophilia-a-in-2026/
LOCATION:EAHAD Academy
CATEGORIES:2026,Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260407T173000
DTEND;TZID=Europe/Brussels:20260407T183000
DTSTAMP:20260506T182556
CREATED:20260409T132716Z
LAST-MODIFIED:20260409T132845Z
UID:30976-1775583000-1775586600@www.eahad.org
SUMMARY:Clinical Implications of Roctavian’s Market Withdrawal
DESCRIPTION:The recent withdrawal of Roctavian from the market has raised important questions for clinicians\, patients\, and healthcare systems involved in the management of haemophilia A gene therapy. As the first approved GT  medicine for adults with severe haemophilia A\, Roctavian represented a significant milestone in the evolution of treatment options\, and the effects of its withdrawal remain to be seen. This online session explores the clinical implications of its withdrawal\, including considerations for patient management\, ongoing monitoring of treated individuals\, and the broader impact on the future of gene therapy in haemophilia. \n\n\n\n\nWatch this insightful discussion on what this development means for clinical practice and the haemophilia community.
URL:https://www.eahad.org/event/clinical-implications-of-roctavians-market-withdrawal/
LOCATION:Online
CATEGORIES:2026,Events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260410
DTEND;VALUE=DATE:20260411
DTSTAMP:20260506T182556
CREATED:20260409T132557Z
LAST-MODIFIED:20260409T133746Z
UID:30972-1775779200-1775865599@www.eahad.org
SUMMARY:E-Learning Module 22: Connecting the Dots: How Hemophilia Guidelines Drive Practice\, Policy\, and Access
DESCRIPTION:
URL:https://www.eahad.org/event/e-learning-module-22-connecting-the-dots-how-hemophilia-guidelines-drive-practice-policy-and-access/
LOCATION:EAHAD Academy
CATEGORIES:2026,Events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260410
DTEND;VALUE=DATE:20260417
DTSTAMP:20260506T182556
CREATED:20251020T173956Z
LAST-MODIFIED:20251020T175041Z
UID:30415-1775779200-1776383999@www.eahad.org
SUMMARY:WFH Congress
DESCRIPTION:The WFH 2026 World Congress will include over 80 hours of continuing educational sessions across the Medical and People with Bleeding Disorders (PWBD) tracks\, as well as six professional development tracks: Nursing\, Dental\, Laboratory Sciences\, Psychosocial\, Musculoskeletal (MSK) and Women and Girls with Bleeding Disorders (WGBD).
URL:https://www.eahad.org/event/wfh-congress/
LOCATION:Kuala Lumpur\, Malaysia\, Malaysia
CATEGORIES:Nurses
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260611
DTEND;VALUE=DATE:20260615
DTSTAMP:20260506T182556
CREATED:20251020T174146Z
LAST-MODIFIED:20251020T174302Z
UID:30419-1781136000-1781481599@www.eahad.org
SUMMARY:EHA2026 Congress
DESCRIPTION:The European Hematology Association (EHA) community consists of doctors (haematologists)\, researchers (PhD or otherwise)\, patients (and advocacy groups)\, geneticists\, nurses\, and more mainly across Europe\, including non-EU member states.
URL:https://www.eahad.org/event/eha2026-congress/
LOCATION:Stockholm\, Sweden\, Sweden
CATEGORIES:Nurses
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260615T170000
DTEND;TZID=Europe/Brussels:20260615T180000
DTSTAMP:20260506T182556
CREATED:20260406T150040Z
LAST-MODIFIED:20260409T133540Z
UID:30990-1781542800-1781546400@www.eahad.org
SUMMARY:Inhibitor Development in Gene Therapy for Haemophilia
DESCRIPTION:Gene therapy is transforming the treatment landscape of hemophilia\, but major questions remain regarding its use in patients with current or past inhibitors. In this webinar\, leading experts will discuss the most challenging clinical and immunological questions\, from mechanisms of liver-induced tolerance to the management of inhibitors developing after gene transfer\, and will debate whether eligibility criteria should evolve in light of emerging data.
URL:https://www.eahad.org/event/inhibitor-development-in-gene-therapy-for-haemophilia/
LOCATION:Online
CATEGORIES:2026,Events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260711
DTEND;VALUE=DATE:20260716
DTSTAMP:20260506T182556
CREATED:20251020T174244Z
LAST-MODIFIED:20251020T175020Z
UID:30422-1783728000-1784159999@www.eahad.org
SUMMARY:ISTH 2026
DESCRIPTION:ISTH is a worldwide not-for-profit organization dedicated to advancing the understanding\, prevention\, diagnosis and treatment of conditions related to thrombosis and haemostasis.
URL:https://www.eahad.org/event/isth-2026/
LOCATION:Paris\, France\, France
CATEGORIES:Nurses
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261005
DTSTAMP:20260506T182556
CREATED:20260417T153605Z
LAST-MODIFIED:20260417T153605Z
UID:31028-1790899200-1791158399@www.eahad.org
SUMMARY:EHC Conference 2026
DESCRIPTION:
URL:https://www.eahad.org/event/ehc-conference-2026/
LOCATION:Istambul
CATEGORIES:Nurses
END:VEVENT
END:VCALENDAR